Alumis Inc.

XNAS:ALMS 4:00:00 PM EDT

22.89

-1.13 (-4.70%)

6:00:23 PM EDT: $23.34 +0.45 (+1.97%)

Market Cap (Intraday)	2.91B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$2.49 Million
Adjusted EPS	-$0.77

See more estimates

10-Day MA	$24.31
50-Day MA	$25.43
200-Day MA	$13.39

See more pivots

Alumis Inc. Stock, XNAS:ALMS

280 East Grand Avenue, San Francisco, California 94080

United States of America

Phone: +1.650.231.6625

Number of Employees:

http://www.alumis.com

Description

Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA.